FasL - Too much of a good thing?

Nature Medicine

Volumn 3, Issue 7, 1997, Pages 727-728

  Lau, Henry T ^a   Stoeckert, Christian J ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; CELL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CELL TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; FAS LIGAND PROTEIN; GENETIC ENGINEERING; ISLETS OF LANGERHANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NEUTROPHILS; TRANSPLANTATION IMMUNOLOGY;

EID: 0030755435     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0797-727     Document Type: Short Survey

References (9)

1. Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632 (1995)
2. Griffith, T.S., Brunner, T., Fletcher, S. M., Green, D. R. & Ferguson, T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192 (1995).
3. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995)
4. Lau, H. T., Yu, M., Fontana, A. & Stoeckert, C. J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112 (1996)
5. Korbutt, G. S., Elliott, J. F. & Rajotte, R.V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46, 317-322 (1997).
6. Kang, S-M. et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3, 738-743 (1997).
7. Chervonsky A.V. et al. The role of Fas in autoimmune diabetes. Cell 89, 17-24 (1997)
8. Allison, J., Georgiou, H. M., Strasser, A. & Vaux, D. L. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allograft. Proc. Nat. Acad. Sci. USA 94, 3943-3947 (1997).
9. Swenson, K. et al. Fas ligand gene transfer prolongs renal allograft survival in rats. Presented at 23rd annual meeting of the American Society of Transplant Surgeons. Chicago, Illinois, May 14th, 1997.